Skip to main content
. 2012 Jul 2;23(3):168–174. doi: 10.3802/jgo.2012.23.3.168

Fig. 1.

Fig. 1

Progression-free and overall survival of no evidence of disease (NED) >18 months and concurrent chemoradiotherapy (CCRT) group.